Guo ZS - Search Results

1

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.

Guo ZS, Liu Z, Bartlett DL. Guo ZS, et al. Front Oncol. 2014 Apr 10;4:74. doi: 10.3389/fonc.2014.00074. eCollection 2014. Front Oncol. 2014. PMID: 24782985 Free PMC article. Review.

2

Vaccinia as a vector for gene delivery.

Guo ZS, Bartlett DL. Guo ZS, et al. Expert Opin Biol Ther. 2004 Jun;4(6):901-17. doi: 10.1517/14712598.4.6.901. Expert Opin Biol Ther. 2004. PMID: 15174972 Review.

3

The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.

Guo ZS, Naik A, O'Malley ME, Popovic P, Demarco R, Hu Y, Yin X, Yang S, Zeh HJ, Moss B, Lotze MT, Bartlett DL. Guo ZS, et al. Cancer Res. 2005 Nov 1;65(21):9991-8. doi: 10.1158/0008-5472.CAN-05-1630. Cancer Res. 2005. PMID: 16267024

4

Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.

Naik AM, Chalikonda S, McCart JA, Xu H, Guo ZS, Langham G, Gardner D, Mocellin S, Lokshin AE, Moss B, Alexander HR, Bartlett DL. Naik AM, et al. Among authors: guo zs. Hum Gene Ther. 2006 Jan;17(1):31-45. doi: 10.1089/hum.2006.17.31. Hum Gene Ther. 2006. PMID: 16409123

5

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ 3rd. Popovic PJ, et al. Among authors: guo zs. J Immunol. 2006 Dec 15;177(12):8701-7. doi: 10.4049/jimmunol.177.12.8701. J Immunol. 2006. PMID: 17142771

6

A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.

Yang S, Guo ZS, O'Malley ME, Yin X, Zeh HJ, Bartlett DL. Yang S, et al. Among authors: guo zs. Gene Ther. 2007 Apr;14(8):638-47. doi: 10.1038/sj.gt.3302914. Epub 2007 Feb 1. Gene Ther. 2007. PMID: 17268533

7

Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.

Hu W, Davis JJ, Zhu H, Dong F, Guo W, Ang J, Peng H, Guo ZS, Bartlett DL, Swisher SG, Fang B. Hu W, et al. Among authors: guo w, guo zs. Cancer Biol Ther. 2007 Nov;6(11):1773-9. doi: 10.4161/cbt.6.11.4855. Epub 2007 Aug 12. Cancer Biol Ther. 2007. PMID: 17986853 Free PMC article.

8

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.

Chalikonda S, Kivlen MH, O'Malley ME, Eric Dong XD, McCart JA, Gorry MC, Yin XY, Brown CK, Zeh HJ 3rd, Guo ZS, Bartlett DL. Chalikonda S, et al. Among authors: guo zs. Cancer Gene Ther. 2008 Feb;15(2):115-25. doi: 10.1038/sj.cgt.7701110. Epub 2007 Dec 14. Cancer Gene Ther. 2008. PMID: 18084242 Free PMC article.

9

Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.

Guo ZS, Thorne SH, Bartlett DL. Guo ZS, et al. Biochim Biophys Acta. 2008 Apr;1785(2):217-31. doi: 10.1016/j.bbcan.2008.02.001. Epub 2008 Feb 15. Biochim Biophys Acta. 2008. PMID: 18328829 Free PMC article. Review.

10

JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase.

Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, Lin A, Swisher SG, Fang B. Hu W, et al. Among authors: guo w, guo zs. Cancer Gene Ther. 2008 Sep;15(9):616-24. doi: 10.1038/cgt.2008.32. Epub 2008 Jun 6. Cancer Gene Ther. 2008. PMID: 18535619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters